Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis

Detalhes bibliográficos
Autor(a) principal: Custódio Deslandes do Passo, Danielle
Data de Publicação: 2020
Outros Autores: Coelho Adati, Marisa, Copello Vigo, Danielle, da Silva Ribeiro, Álvaro, Machado Passo, Roberto, Pereira da Silva Zamith, Helena
Tipo de documento: Artigo
Idioma: por
eng
Título da fonte: Vigilância Sanitária em Debate
Texto Completo: https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562
Resumo: Introduction: Syphilis is a slowly evolving infectious disease caused by a gram-negative bacterium in the group of spirochetes, exclusive to humans, called Treponema pallidum. In the fight against syphilis, an important tool is the laboratory analysis through products for in vitro diagnosis that allows the diagnosis of the disease. The effectiveness of these products is assessed against serological panels composed of true positive and negative samples. Objective: To reassess the reactivity of the 153 samples that make up the positive serological panel for  syphilis at the Laboratory of Blood and Blood Products (LSH) of the National Institute for Quality Control in Health (INCQS). Method: Revalidation of the serological panel for syphilis through retrospective analysis of LSH laboratory data from 2011 to 2015, meeting the positivity criteria in 5 different methodologies and sample volume ≥ 10 mL. Results: Of the 172 initial samples, 153 had stock volume ≥ 10 mL. In the proposed period, 46 syphilis diagnosis products were identified with a satisfactory report, comprising 5 different methodologies. The analytical results of the 153 samples belonging to the positive panel were analyzed in the protocols for recording the results of these products. After re-evaluating the reactivity of the 153 samples from the positive panel 130, they were revalidated as positive while 23 were considered to be indeterminate. Conclusions: The positive panel for revalidated syphilis will remain an essential instrument in the previous analysis for the purpose of regularizing kits for diagnosing the disease.
id FIOCRUZ-9_a7e4e7b6fcf30e72db627017df4138ff
oai_identifier_str oai:ojs.visaemdebate.incqs.fiocruz.br:article/1562
network_acronym_str FIOCRUZ-9
network_name_str Vigilância Sanitária em Debate
repository_id_str
spelling Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosisRevalidação do painel sorológico positivo para sífilis – uma ferramenta no controle da qualidade de kits para diagnóstico da sífilisSífilis; Painel Sorológico; Controle de QualidadeIntroduction: Syphilis is a slowly evolving infectious disease caused by a gram-negative bacterium in the group of spirochetes, exclusive to humans, called Treponema pallidum. In the fight against syphilis, an important tool is the laboratory analysis through products for in vitro diagnosis that allows the diagnosis of the disease. The effectiveness of these products is assessed against serological panels composed of true positive and negative samples. Objective: To reassess the reactivity of the 153 samples that make up the positive serological panel for  syphilis at the Laboratory of Blood and Blood Products (LSH) of the National Institute for Quality Control in Health (INCQS). Method: Revalidation of the serological panel for syphilis through retrospective analysis of LSH laboratory data from 2011 to 2015, meeting the positivity criteria in 5 different methodologies and sample volume ≥ 10 mL. Results: Of the 172 initial samples, 153 had stock volume ≥ 10 mL. In the proposed period, 46 syphilis diagnosis products were identified with a satisfactory report, comprising 5 different methodologies. The analytical results of the 153 samples belonging to the positive panel were analyzed in the protocols for recording the results of these products. After re-evaluating the reactivity of the 153 samples from the positive panel 130, they were revalidated as positive while 23 were considered to be indeterminate. Conclusions: The positive panel for revalidated syphilis will remain an essential instrument in the previous analysis for the purpose of regularizing kits for diagnosing the disease.Introdução: A sífilis é uma doença infecciosa de evolução lenta causada por uma bactéria Gramnegativa do grupo das espiroquetas, exclusiva do ser humano, chamada Treponema pallidum.  No combate da sífilis, uma importante ferramenta é a análise laboratorial através de produtos para diagnóstico in vitro que permite o diagnóstico da doença. A eficácia destes produtos é  avaliada frente a painéis sorológicos compostos por amostras verdadeiro positivas e negativas. Objetivo: Reavaliar a reatividade das 153 amostras que constituem o painel sorológico positivo para sífilis do Laboratório de Sangue e Hemoderivados (LSH) do Instituto Nacional de Controle de Qualidade em Saúde (INCQS). Método: Revalidação do painel sorológico para sífilis através de análise retrospectiva de dados laboratoriais do LSH do período de 2011 a 2015 atendendo aos critérios de positividade em cinco metodologias diferentes e volume de amostra ≥ 10 mL.  Resultados: Das 172 amostras iniciais, 153 apresentaram volume de estoque ≥ 10 mL. No período proposto foram identificados 46 produtos para diagnóstico da sífilis com laudo satisfatório compreendendo cinco metodologias diferentes. Os resultados analíticos das 153 amostras pertencentes ao painel positivo foram analisados nos protocolos de registro de resultados destes produtos. Após a reavaliação da reatividade das 153 amostras do painel positivo, 130 foram revalidadas como positivas enquanto 23 foram consideradas como indeterminadas. Conclusões: O painel positivo para sífilis revalidado permanecerá sendo instrumento essencial na análise  prévia para fins de regularização dos kits para diagnóstico da doença.Instituto Nacional de Controle de Qualidade em Saúde2020-11-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion"Peer-reviewed article""Artículo revisado por pares""Artigo avaliado pelos pares"application/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562Health Surveillance under Debate: Society, Science & Technology ; Vol. 8 No. 4 (2020): November - Monitoramento & Avaliação em Vigilância Sanitária; 129-133Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 8 Núm. 4 (2020): Noviembre - Monitoramento & Avaliação em Vigilância Sanitária; 129-133Vigil Sanit Debate, Rio de Janeiro; v. 8 n. 4 (2020): Novembro - Monitoramento & Avaliação em Vigilância Sanitária; 129-1332317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562/1268https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562/1307Copyright (c) 2020 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by/3.0/deed.pt_BRinfo:eu-repo/semantics/openAccessCustódio Deslandes do Passo, Danielle Coelho Adati, Marisa Copello Vigo, Danielle da Silva Ribeiro, Álvaro Machado Passo, Roberto Pereira da Silva Zamith, Helena 2023-06-27T15:13:00Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1562Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T15:13Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis
Revalidação do painel sorológico positivo para sífilis – uma ferramenta no controle da qualidade de kits para diagnóstico da sífilis
title Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis
spellingShingle Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis
Custódio Deslandes do Passo, Danielle
Sífilis; Painel Sorológico; Controle de Qualidade
title_short Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis
title_full Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis
title_fullStr Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis
title_full_unstemmed Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis
title_sort Revalidation of the positive serological panel for syphilis – a tool in the quality control of kits for syphilis diagnosis
author Custódio Deslandes do Passo, Danielle
author_facet Custódio Deslandes do Passo, Danielle
Coelho Adati, Marisa
Copello Vigo, Danielle
da Silva Ribeiro, Álvaro
Machado Passo, Roberto
Pereira da Silva Zamith, Helena
author_role author
author2 Coelho Adati, Marisa
Copello Vigo, Danielle
da Silva Ribeiro, Álvaro
Machado Passo, Roberto
Pereira da Silva Zamith, Helena
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Custódio Deslandes do Passo, Danielle
Coelho Adati, Marisa
Copello Vigo, Danielle
da Silva Ribeiro, Álvaro
Machado Passo, Roberto
Pereira da Silva Zamith, Helena
dc.subject.por.fl_str_mv Sífilis; Painel Sorológico; Controle de Qualidade
topic Sífilis; Painel Sorológico; Controle de Qualidade
description Introduction: Syphilis is a slowly evolving infectious disease caused by a gram-negative bacterium in the group of spirochetes, exclusive to humans, called Treponema pallidum. In the fight against syphilis, an important tool is the laboratory analysis through products for in vitro diagnosis that allows the diagnosis of the disease. The effectiveness of these products is assessed against serological panels composed of true positive and negative samples. Objective: To reassess the reactivity of the 153 samples that make up the positive serological panel for  syphilis at the Laboratory of Blood and Blood Products (LSH) of the National Institute for Quality Control in Health (INCQS). Method: Revalidation of the serological panel for syphilis through retrospective analysis of LSH laboratory data from 2011 to 2015, meeting the positivity criteria in 5 different methodologies and sample volume ≥ 10 mL. Results: Of the 172 initial samples, 153 had stock volume ≥ 10 mL. In the proposed period, 46 syphilis diagnosis products were identified with a satisfactory report, comprising 5 different methodologies. The analytical results of the 153 samples belonging to the positive panel were analyzed in the protocols for recording the results of these products. After re-evaluating the reactivity of the 153 samples from the positive panel 130, they were revalidated as positive while 23 were considered to be indeterminate. Conclusions: The positive panel for revalidated syphilis will remain an essential instrument in the previous analysis for the purpose of regularizing kits for diagnosing the disease.
publishDate 2020
dc.date.none.fl_str_mv 2020-11-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
"Peer-reviewed article"
"Artículo revisado por pares"
"Artigo avaliado pelos pares"
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562
url https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562
dc.language.iso.fl_str_mv por
eng
language por
eng
dc.relation.none.fl_str_mv https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562/1268
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1562/1307
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/3.0/deed.pt_BR
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/3.0/deed.pt_BR
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
publisher.none.fl_str_mv Instituto Nacional de Controle de Qualidade em Saúde
dc.source.none.fl_str_mv Health Surveillance under Debate: Society, Science & Technology ; Vol. 8 No. 4 (2020): November - Monitoramento & Avaliação em Vigilância Sanitária; 129-133
Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 8 Núm. 4 (2020): Noviembre - Monitoramento & Avaliação em Vigilância Sanitária; 129-133
Vigil Sanit Debate, Rio de Janeiro; v. 8 n. 4 (2020): Novembro - Monitoramento & Avaliação em Vigilância Sanitária; 129-133
2317-269X
reponame:Vigilância Sanitária em Debate
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Vigilância Sanitária em Debate
collection Vigilância Sanitária em Debate
repository.name.fl_str_mv Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br
_version_ 1797042045941972992